Cardiovascular & Hematological Disorders-Drug Targets
Formerly: Current Drug Targets - Cardiovascular & Hematological Disorders
Volume 22, 4 Issues, 2022
ISSN: 2212-4063 (Online)
ISSN: 1871-529X (Print)
This journal supports open access
ISSN: 2212-4063 (Online)
ISSN: 1871-529X (Print)
This journal supports open access
Contents
Cardiovascular & Hematological Disorders-Drug Targets , Volume 17 - Number 1
Biography
Preface
Research Article
Effects of an Outpatient Service Rehabilitation Programme in Patients Affected by Pulmonary Arterial Hypertension: An Observational Study
, 17(1): 3 - 10Maurizio Bussotti*, Paola Gremigni, Roberto F.E. Pedretti, Patrycja Kransinska, Silvia Di Marco, Paola Corbo, Giovanni Marchese, Paolo Totaro and Marinella Sommaruga
DOI: 10.2174/1871529X16666161130123937
Research Article
Evaluation of Antidiabetic Activity of Carnosol (Phenolic Diterpene in Rosemary) in Streptozotocin-Induced Diabetic Rats
, 17(1): 11 - 17Saeed Samarghandian*, Abasalt Borji and Tahere Farkhondeh
DOI: 10.2174/1871529X16666161229154910
Research Article
Alcohol Induced Hepato Cardiotoxicity and Oxidative Damage in Rats: The Protective Effect of n-butanol Extract of Green Tea (Camellia sinensis (L.) Kuntze)
, 17(1): 18 - 23Amel Amrani*, Nassima Boubekri, Somia Lassad, Djamila Zama, Fadil Benayache and Samir Benayache
DOI: 10.2174/1871529X17666170310101727
Research Article
Comparison of the Acute Hematopoietic Capacities of Erythropoietin and U-74389G Concerning Hematocrit Levels
, 17(1): 24 - 27Constantinos Tsompos*, Constantinos Panoulis, Konstantinos Toutouzas, Aggeliki Triantafyllou, George Zografos and Apostolos Papalois
DOI: 10.2174/1871529X17666170201104158
Research Article
The sdLDL Reduces MRC1 Expression Level and Secretion of Histamin e in Differentiated M2-macrophages from Patients with Coronary Artery Stenosis
, 17(1): 28 - 32Ameneh Yarnazari, Parisa Hassanpour, Syed Reza Hosseini-Fard, Abdollah Amirfarhangi and Mohammad Najafi*
DOI: 10.2174/1871529X17666170106095554
Review Article
Should Arterial Embolization in Recurrent Spontaneous Hemoph ilic Hemarthroses Refractory to Intensive Prophylaxis be the First Invas ive Resort?
, 17(1): 33 - 37E. Carlos Rodriguez-Merchan*
DOI: 10.2174/1871529X17666161216112745
Review Article
Is there any Role for Splenectomy in Adulthood Onset Chronic Immun e Thrombocytopenia in the Era of TPO Receptors Agonists? A Critic al Overview
, 17(1): 38 - 51Milunovic Vibor*, Inga Mandac Rogulj and Slobodanka Kolonic Ostojic
DOI: 10.2174/1871529X16666161229155608
Review Article
Guide of Hypertensive Crisis Pharmacotherapy
, 17(1): 52 - 57Priyanka Wani-Parekh*, Carlos Blanco-Garcia, Melissa Mendez and Debabrata Mukherjee
DOI: 10.2174/1871529X16666161220142020
Review Article
Biomarker Assays for Personalised Stroke Risk Assessment in Atrial Fibrillation
, 17(1): 58 - 63Angela Hall, Rupert F.G. Simpson and Andrew R.J. Mitchell*
DOI: 10.2174/1871529X17666170104120746
Review Article
Targeting the Role of Lipoprotein (a) in Stroke
, 17(1): 64 - 72Zahra Mazhar, Andrew Hughes and Mahdi Garelnabi*
DOI: 10.2174/1871529X17666170421150028
Editor-in-Chief
Garry X. Shen
Department of Internal Medicine
University of Manitoba
Winnipeg, MB
(Canada)
Biography
Department of Internal Medicine
University of Manitoba
Winnipeg, MB
Biography
Biography of Garry X. Shen
Dr. Shen is the Professor in the Departments of Internal Medicine in the University of Manitoba. He graduated and received Master and Doctorial degrees from Shanghai Jiaotong University School of Medicine, and worked as physician in Shanghai Institute of Hypertension and Department of Cardiology in Shanghai Ruijin Hospital. He received postdoctoral training in University of Iowa, Cleveland Clinical Foundation, and University of Alberta. He has joined the Section of Endocrinology, Department of Internal Medicine, Faculty of Medicine in University of Manitoba since 1991 and promoted as Professor in 2006. His research program aims to mechanism and management of for diabetic cardiovascular complications and gestational diabetes. He published >100 peer reviewed papers and received a number of national and international awards and recognitions including Editor-in-Chief of Cardiovascular and Hematological Disorders-Drug Target, Advisory Professor in Shanghai Jiaotong University School of Medicine, and Councilor of Canadian Society of Atherosclerosis, Thrombosis and Vascular Biology.
COPE Compliant
About the Journal
⇨ Journal Home⇨ Editorial Policies⇨ Fabricating and Stating False Information⇨ Research Misconduct⇨ Allegations from Whistleblowers⇨ Editorial Board⇨ Meet the Executive Guest Editor(s)⇨ Board Recruitment Workflow⇨ Join Editorial Board⇨ Indexing Information⇨ Announcements⇨ Endorsements⇨ Authors' Comments⇨ Special Offers
For Authors
For Librarians & Readers
Quick Links
Journal History
Cardiovascular and Hematological Disorders-drug Targets was launched in 2001. Dr. Garry X. Shen serves as the Editor-in-Chief of the journal.
New eBook
 |
Frontiers in Clinical Drug Research-HematologyYou can view the contents of this eBook [here] or purchase it [here]. |
Webmaster Contact: info@benthamscience.net